Chen Sheng, Ni Wang, Yin Xin-Zhen, Liu Han-Qiu, Lu Cong, Zheng Qiao-Juan, Zhao Gui-Xian, Xu Yong-Feng, Wu Lei, Zhang Liang, Wang Ning, Li Hong-Fu, Wu Zhi-Ying
Department of Neurology and Research Center of Neurology in Second Affiliated Hospital, The Collaborative Innovation Center for Brain Science, Zhejiang University School of Medicine, Hangzhou, China.
Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
CNS Neurosci Ther. 2017 Sep;23(9):707-716. doi: 10.1111/cns.12719. Epub 2017 Jul 14.
To characterize clinical features and mutation spectrum in Chinese patients with CADASIL.
We collected 261 clinically suspected Chinese CADASIL patients from three hospitals located in different regions of China. Sanger sequencing is performed to screen the exons 2 to 24 of NOTCH3 gene. Clinical and genetic data were retrospectively studied. Haplotype analyses were performed in patients carrying p.Arg544Cys and p.Arg607Cys, respectively.
A total of 214 patients were finally genetically diagnosed as CADASIL, with 45 known NOTCH3 mutations and a novel c.1817G>T mutation. We found that patients carrying p.Arg607Cys or p.Arg544Cys mutation located in exon 11 occupied nearly 35% in our mutation spectrum. In retrospectively study of clinical data, we found a higher number of patients having cognitive impairment and a lower number of patients having migraine with aura. Furthermore, we identified that patients carrying mutations in exon 11 seemed to experience a later disease onset (p=6.8×10 ). Additionally, a common haplotype was found in patients from eastern China carrying p.Arg607Cys, and the patients from Fujian carrying p.Arg544Cys shared the same haplotype with patients from Taiwan carrying p.Arg544Cys.
These findings broaden the mutational and clinical spectrum of CADASIL and provide additional evidences for the existence of founder effect in CADASIL patients.
明确中国伴有皮质下梗死和白质脑病的常染色体显性遗传性脑动脉病(CADASIL)患者的临床特征和突变谱。
我们从中国不同地区的三家医院收集了261例临床疑似CADASIL的中国患者。采用桑格测序法筛查NOTCH3基因的第2至24外显子。对临床和遗传数据进行回顾性研究。分别对携带p.Arg544Cys和p.Arg607Cys突变的患者进行单倍型分析。
共有214例患者最终被基因诊断为CADASIL,发现45种已知的NOTCH3突变和一种新的c.1817G>T突变。我们发现,携带位于第11外显子的p.Arg607Cys或p.Arg544Cys突变的患者在我们的突变谱中占近35%。在临床数据的回顾性研究中,我们发现认知障碍患者数量较多,而有先兆偏头痛患者数量较少。此外,我们发现携带第11外显子突变的患者似乎发病较晚(p = 6.8×10)。此外,在中国东部携带p.Arg607Cys突变的患者中发现了一种常见单倍型,福建携带p.Arg544Cys突变的患者与台湾携带p.Arg544Cys突变的患者共享相同单倍型。
这些发现拓宽了CADASIL的突变和临床谱,并为CADASIL患者中存在奠基者效应提供了更多证据。